Not exact matches
In February, the United Kingdom approved using the method
on human embryos at the Francis Crick Institute in London, but only within a narrow capacity: Researchers can
edit genes in non-viable human embryos for a limited period and only to
study developmental biology related to in vitro fertilization.
An editorial posted online
on 28 April says the journal's objective in publishing the
study was «the sounding of an alarm to draw immediate attention to the urgent need to rein in applications of
gene -
editing technologies, especially in the human germ cells or embryos.»
He is Member of the European Molecular Biology Organization (EMBO), has been President of the European Society of
Gene and Cell Therapy (ESGCT), and has been appointed as expert
on the «Human
Gene Editing Study» of the US National Academies of Sciences and of Medicine, and
on the Italian National Committee for Biosafety, Biotechnology and Life Sciences.
In the new
study, Duke University researchers overcame several of these obstacles by using a non-pathogenic carrier called adeno - associated virus, or AAV, to deliver the
gene -
editing system.The paper appears
on December 31, 2015 in Science.